Literature DB >> 12027852

Cerebral blood flow, oxidative metabolism and cerebrovascular carbon dioxide reactivity in patients with acute bacterial meningitis.

K Møller1, G I Strauss, G Thomsen, F S Larsen, S Holm, B K Sperling, P Skinhøj, G M Knudsen.   

Abstract

BACKGROUND: The optimal arterial carbon dioxide tension (P(a)CO(2)) in patients with acute bacterial meningitis (ABM) is unknown and controversial. The objective of this study was to measure global cerebral blood flow (CBF), cerebrovascular CO(2) reactivity (CO(2)R), and cerebral metabolic rates (CMR) of oxygen (O(2)), glucose (glu), and lactate (lac), in patients with ABM and compare the results to those obtained in healthy volunteers.
METHODS: We studied 19 patients (17 of whom were sedated) with ABM and eight healthy volunteers (controls). CBF was measured during baseline ventilation and hyperventilation with single-photon emission computed tomography (SPECT) (14 patients) and/or the Kety-Schmidt technique (KS) (11 patients and all controls). In KS studies, CMR was measured by multiplying the arterial to jugular venous concentration difference (a-v D) by CBF.
RESULTS: CBF did not differ significantly among groups, although a larger variation was seen in patients than in controls. CO(2)R was not significantly different among groups. At baseline, patients had significantly lower a-v DO(2), CMR(O(2)), CMR(glu), and CMR(lac) than controls. CMR(O(2)) did not change between hyperventilation compared to baseline ventilation, whereas CMR(glu) increased.
CONCLUSION: In patients with acute bacterial meningitis, we found variable levels of CBF and cerebrovascular CO(2) reactivity, a low a-v DO(2), low cerebral metabolic rates of oxygen and glucose, and a cerebral lactate efflux. In these patients, a ventilation strategy guided by jugular bulb oximetry and/or repeated CBF measurements may be more optimal in terms of cerebral oxygenation than a strategy aiming at identical levels of P(a)CO(2) for all patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027852     DOI: 10.1034/j.1399-6576.2002.460515.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

1.  Meningococcal meningitis.

Authors:  Ricardo G Branco; Robert C Tasker
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

2.  Effect of bacterial meningitis complicating severe head trauma upon brain microdialysis and cerebral perfusion.

Authors:  Anna Teresa Mazzeo; Ross Bullock
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  The oxygen paradox of neurovascular coupling.

Authors:  Christoph Leithner; Georg Royl
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-23       Impact factor: 6.200

4.  Raised intracranial pressure during CNS infection: what should we do about it?*.

Authors:  Robert C Tasker
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

5.  Neuron-Specific Enolase Is Correlated to Compromised Cerebral Metabolism in Patients Suffering from Acute Bacterial Meningitis; An Observational Cohort Study.

Authors:  Jiri Bartek; Eric Peter Thelin; Per Hamid Ghatan; Martin Glimaker; Bo-Michael Bellander
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

6.  Argon does not affect cerebral circulation or metabolism in male humans.

Authors:  Frank Grüne; Stephan Kazmaier; Sanne Elisabeth Hoeks; Robert Jan Stolker; Marc Coburn; Andreas Weyland
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

7.  Prospective observational cohort study of cerebrovascular CO2 reactivity in patients with inflammatory CNS diseases.

Authors:  D Lepur; M Kutleša; B Baršić
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-29       Impact factor: 3.267

8.  Differential influence of arterial blood glucose on cerebral metabolism following severe traumatic brain injury.

Authors:  Monika Holbein; Markus Béchir; Silke Ludwig; Jutta Sommerfeld; Silvia R Cottini; Marius Keel; Reto Stocker; John F Stover
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.